# LIDOCAINE HYDROCHLORIDE
> **ANDA214336** · Abbreviated New Drug Application (Generic) · Sponsor: ASPIRO · Approved 2021-11-08
## Drug
- **FDA Application Number:** ANDA214336
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** LIDOCAINE HYDROCHLORIDE
- **Generic name:** LIDOCAINE HYDROCHLORIDE
- **Active ingredients:** LIDOCAINE HYDROCHLORIDE
- **Dosage form:** INJECTABLE
- **Route:** INJECTION
- **Marketing status:** Prescription
- **Sponsor:** ASPIRO
- **Manufacturer:** Camber Pharmaceuticals, Inc.
- **First approval:** 2021-11-08
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214336)
---
*AI Analytics · CC0 1.0*